295 related articles for article (PubMed ID: 11846426)
1. Evaluation of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus in mAb cell-culture.
Brorson K; Xu Y; Swann PG; Hamilton E; Mustafa M; de Wit C; Norling LA; Stein KE
Biologicals; 2002 Mar; 30(1):15-26. PubMed ID: 11846426
[TBL] [Abstract][Full Text] [Related]
2. Use of a quantitative product-enhanced reverse transcriptase assay to monitor retrovirus levels in mAb cell-culture and downstream processing.
Brorson K; Swann PG; Lizzio E; Maudru T; Peden K; Stein KE
Biotechnol Prog; 2001; 17(1):188-96. PubMed ID: 11170498
[TBL] [Abstract][Full Text] [Related]
3. A modified single-tube one-step product-enhanced reverse transcriptase (mSTOS-PERT) assay with heparin as DNA polymerase inhibitor for specific detection of RTase activity.
Fan XY; Lü GZ; Wu LN; Chen JH; Xu WQ; Zhao CN; Guo SQ
J Clin Virol; 2006 Dec; 37(4):305-12. PubMed ID: 16971176
[TBL] [Abstract][Full Text] [Related]
4. A novel, Q-PCR based approach to measuring endogenous retroviral clearance by capture protein A chromatography.
Zhang M; Lute S; Norling L; Hong C; Safta A; O'Connor D; Bernstein LJ; Wang H; Blank G; Brorson K; Chen Q
Biotechnol Bioeng; 2009 Apr; 102(5):1438-47. PubMed ID: 18988264
[TBL] [Abstract][Full Text] [Related]
5. Real-time quantitative PCR for retrovirus-like particle quantification in CHO cell culture.
de Wit C; Fautz C; Xu Y
Biologicals; 2000 Sep; 28(3):137-48. PubMed ID: 10964440
[TBL] [Abstract][Full Text] [Related]
6. Practical assay issues with the PERT/PBRT assay: a highly sensitive reverse transcriptase assay.
Chang A; Dusing S
Dev Biol (Basel); 2006; 123():91-7; discussion 119-32. PubMed ID: 16566438
[TBL] [Abstract][Full Text] [Related]
7. A comparison of methods for the estimation of retroviral burden.
Bierley ST; Raineri R; Poiley JA; Morgan EM
Dev Biol Stand; 1996; 88():163-5. PubMed ID: 9119132
[TBL] [Abstract][Full Text] [Related]
8. Real time quantitative PCR as a method to evaluate xenotropic murine leukemia virus removal during pharmaceutical protein purification.
Shi L; Chen Q; Norling LA; Lau AS; Krejci S; Xu Y
Biotechnol Bioeng; 2004 Sep; 87(7):884-96. PubMed ID: 15334415
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of different RT enzyme standards for quantitation of retroviruses using the single-tube fluorescent product-enhanced reverse transcriptase assay.
Ma YK; Khan AS
J Virol Methods; 2009 May; 157(2):133-40. PubMed ID: 19186191
[TBL] [Abstract][Full Text] [Related]
10. Impact of cell culture process changes on endogenous retrovirus expression.
Brorson K; De Wit C; Hamilton E; Mustafa M; Swann PG; Kiss R; Taticek R; Polastri G; Stein KE; Xu Y
Biotechnol Bioeng; 2002 Nov; 80(3):257-67. PubMed ID: 12226857
[TBL] [Abstract][Full Text] [Related]
11. Preferential replication of murine xenotropic type-C virus in human lymphosarcoma-derived cell lines.
Grófová M; Popovic M; Matoska J; Nilsson K; Vlasenkova NK; Thurzo V
Neoplasma; 1979; 26(3):241-50. PubMed ID: 93707
[TBL] [Abstract][Full Text] [Related]
12. Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant.
Deichmann M; Huder JB; Kleist C; Näher H; Schüpbach J; Böni J
Arch Dermatol Res; 2005 Feb; 296(8):345-52. PubMed ID: 15630577
[TBL] [Abstract][Full Text] [Related]
13. Specific suppression of false-positive signals in the product-enhanced reverse transcriptase assay.
Lugert R; König H; Kurth R; Tönjes RR
Biotechniques; 1996 Feb; 20(2):210-7. PubMed ID: 8825150
[TBL] [Abstract][Full Text] [Related]
14. Reverse transcriptase activity in tissues of the soft shell clam Mya arenaria affected with haemic neoplasia.
AboElkhair M; Synard S; Siah A; Pariseau J; Davidson J; Johnson G; Greenwood SJ; Casey JW; Berthe FC; Cepica A
J Invertebr Pathol; 2009 Oct; 102(2):133-40. PubMed ID: 19632237
[TBL] [Abstract][Full Text] [Related]
15. Experiences of virus, retrovirus and retrovirus-like particles in Chinese hamster ovary (CHO) and hybridoma cells used for production of protein therapeutics.
Adamson SR
Dev Biol Stand; 1998; 93():89-96. PubMed ID: 9737383
[TBL] [Abstract][Full Text] [Related]
16. The retrovirus particles in human myeloma cells RPMI8226: morphological, biochemical, immunological and infective transmission studies.
Grófová M; Popovic M; Ogura H; Matoska J; Lizonová A; Nilsson K; Kuzela S
Neoplasma; 1978; 25(4):423-37. PubMed ID: 80755
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of RT activity by PERT assay: feasibility and limits to a standardized screening assay for human vaccines.
André M; Morgeaux S; Fuchs F
Biologicals; 2000 Jun; 28(2):67-80. PubMed ID: 10885614
[TBL] [Abstract][Full Text] [Related]
18. Recent studies on retrovirus-like particles in Chinese hamster ovary cells.
Dinowitz M; Lie YS; Low MA; Lazar R; Fautz C; Potts B; Sernatinger J; Anderson K
Dev Biol Stand; 1992; 76():201-7. PubMed ID: 1282476
[TBL] [Abstract][Full Text] [Related]
19. Constitutive production of a murine retrovirus in the human B-lymphoblastoid cell line, DG-75.
Raisch KP; Kushnaryov VM; Grossberg SE; Cashdollar LW
Virology; 1998 Oct; 250(1):135-9. PubMed ID: 9770427
[TBL] [Abstract][Full Text] [Related]
20. High throughput detection of retrovirus-associated reverse transcriptase using an improved fluorescent product enhanced reverse transcriptase assay and its comparison to conventional detection methods.
Lovatt A; Black J; Galbraith D; Doherty I; Moran MW; Shepherd AJ; Griffen A; Bailey A; Wilson N; Smith KT
J Virol Methods; 1999 Oct; 82(2):185-200. PubMed ID: 10894635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
